These data indicate that preventing CaMKII-dependent phosphorylation of Nav1.5 leads to improved metabolic health in addition to having a protective effect on atrial remodeling and reduced susceptibility to arrhythmia. This evidence concerns the gene CAMK2G and cardiac arrhythmia.